Abstract. Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-ß superfamily. Recent studies have showed that aberrant methylation of BMP genes is present in several types of human cancer. We examined the expression and methylation status of BMP3b and BMP6 in malignant pleural mesotheliomas (MPMs). The expression status of BMP3b, and BMP6 mRNAs were examined in seven MPM cell lines by RT-PCR assay. The expression of BMP3b was completely suppressed in 2 and partially suppressed in 2 of 7 cell lines and expression of BMP6 was partially suppressed in 2 cell lines. Methylation status of BMP3b in cell lines was determined by methylation-specific assay to find aberrant methylation in 6 cell lines which include 4 cell lines with suppressed BMP3b expression. Partial methylation of BMP6 was found in 2 cell lines whose expression was partially suppressed. Treatment with 5-Aza-dC restored BMP3b expression in methylated cell lines. Next, we examined the methylation status in 57 surgically resected MPM cases and found aberrant methylation of BMP3b in 9 (53%) out of 17 cases from Japan and 3 (8%) of 40 cases from USA and that of BMP6 in 4 (24%) cases from Japan and 12 (30%) cases from USA, showing significant difference in frequency of BMP3b methylation between MPMs of the two countries (P=0.0004). Our study indicated that BMP3b and BMP6 genes were suppressed by DNA methylation and methylation of BMP3b is significantly frequent in Japanese MPMs, suggesting its pathogenic role and the ethnic difference in MPMs.
Introduction
Bone morphogenetic proteins (BMPs) are multifunctional cytokines involved in skeletal development and bone formation (1, 2) . They are members of the transforming growth factor-ß (TGF-ß) superfamily and critical mediators of early embryonic patterning. BMPs have been shown to inhibit cellular proliferation and be involved in organogenesis, particularly of the lung, heart and kidney. Inactivation of BMP genes has been implicated as important in several cancer types (3) (4) (5) (6) (7) (8) . Recent studies have shown that BMP genes including BMP3, BMP3b and BMP6 are epigenetically inactivated in various kinds of cancers, suggesting that inactivation of BMPs may play an important role in carcino-genesis. BMP3b is methylated in colorectal neoplasms and non-small cell lung cancers (NSCLCs), while BMP6 is methylated in breast cancer and NSCLCs.
Malignant pleural mesothelioma (MPM) is an aggressive tumor that develops from the pleural surface. The strong association with exposure to asbestos is known and implication of SV40 infection has been revealed recently (9, 10) . Regarding molecular alteration of MPM, homozygous deletion of p16 gene and mutation of neurofibromatosis type 2 gene are well known as genetic alteration of MPM. DNA methylations of several tumor suppressor genes are also known as epigenetic alteration of MPMs (11) (12) (13) .
In this study, we examined the methylation and expression status of BMP3b and BMP6 genes in primary MPMs and MPM cell lines to investigate the implication of BMP genes in MPMs. Seven MPM cell lines (NCI-H2452, NCI-H2373, NCI-H2058, NCI-H2052, NCI-H290, NCI-H28, HP1) were kindly gifted from Ad.F. Gazdar (Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX) or Harvery I. Pass (Department of Cardiothoracic Surgery, NYU School of Medicine). All these cell line samples were maintained in RPMI-1640 medium (Sigma Chemical Co., St. Louis, MO) supplemented with 10% fetal bovine serum. Surgically resected specimens of 57 MPMs were obtained after informed consent from each patient. Tumor tissues were obtained from 40 patients with MPMs resected at Karmanos Cancer Center, MI, 6 patients resected at Okayama Rousai Hospital (Okayama, Japan), 5 patients at NHO Sanyo National Hospital, Yamaguchi Japan, and 6 patients at Okayama University Hosipital, Okayama Japan. The study was approved by the Institutional Review Board of each institution and informed consent was obtained from the patients.
Materials and methods

Tumor samples and cell lines.
Reverse transcription polymerase chain reaction (RT-PCR).
The expression status of BMP3b and BMP6 mRNAs were examined in seven MPM cell lines by RT-PCR assay. Total-RNA was isolated using RNeasy mini kit™ (Qiagen, Valencia, CA). cDNA was synthesized from the RNA using the SuperScript II kit (Invitogen, Carlsbad, CA). RT-RCR amplification of BMP3b and BMP6 cDNA was performed using primers designed with Primer 3. BMP3b primers used were: 5'-GGTGGACTTCGCAGACATCG-3' (sense) and 5'-GATGGTGGCATGGTTGGATG-3' (antisense). BMP6 primers were: 5'-ACAGCATAACATGGGGCTTC-3' (sense) and 5'-CTCGGGGTTCATAAGGTGAA-3' (antisense). GAPDH was used as an internal control to confirm the success of the RT reaction (sense primer, 5'-ACAGTCCATGCCA TCACTGCC-3' and antisense primer, 5'-GCCTGCTTCA CCACCTTCTTG-3') (14) . The PCR mixture contained 10X PCR buffer, dNTPs (200 μM of each), primers (1 μM of each) and 0.25 μl TaqGold. cDNA was amplified using an annealing temperature at 60˚C and two different cycles of 17 and 35 cycles. PCR product was separated by electrophoresis and visualized on an ethidium bromide-stained agarose gel.
DNA extraction and bisulfite treatment. Genomic DNA was isolated from cell lines and frozen tissues of primary tumors by homogenization by digestion with 100 μg/ml, SDS/ proteinase K followed by standard phenol-chloroform (1:1) extraction, and ethanol precipitation. One microgram of extracted DNA was modified with bisulfate treatment using the EZ DNA Methylation kit™ (Zymo Research, Orange, CA) according to the manufacturer's instructions.
Methylation-specific PCR assay. Aberrant methylation of
BMP3b and BMP6 genes was determined by MSP assay using DNAs treated with sodium bisulfite as described previously. The primer sets for both methylated and unmethylated forms of each gene were prepared. The primers to BMP3b promoter region were: 5'-CGGCGTCGATATATAGGAGTC-3' (sense) and 5'-AAATCGTCCCTAACCCGACT-3' (antisense) for methylated form and 5'-TGGTGTTGATATA TAGGAGTT-3' (sense) and 5'-AAATCATCCCTAACCCA ACT-3' (antisense) for unmethylated form. The primers for BMP6 were: 5'-GGTTTGTTGGGTAGTCGGG-3' (sense) and 5'-GCCCCTCCCCAAATCG-3' (antisense) for methylated form and 5'-TTGGGTAGTTGGGTGATTGTT-3' (sense) and 5'-ACACCCCTCCCCAAATCA-3' (antisense) for unmethylated form. Bisulfite-modefied DNAs were mixed with 10X PCR Buffer, 150 μM of deoxynucleotide triphosphates, 0.4 μM of primers and 1 unit of HotStar Taq (Qiagen). The PCR condition for methylated alleles of BMP3b consisted of 12 min at 95˚C, 40 cycles of 30 sec of 95˚C, 60 sec of 61˚C and 60 sec of 72˚C followed 7 min elongation. The PCR condition for unmethylated alleles of BMP3b was similar to that for methylated allele: 12 min at 95˚C, 40 cycles of 30 sec of 95˚C, 60 sec of 56˚C and 60 sec of 72˚C followed 7 min elongation. The PCR condition for methylated alleles of BMP6 consisted of 12 min at 95˚C, 40 cycles of 30 sec of 95˚C, 60 sec of 62˚C and 60 sec of 72˚C, followed 7 min elongation. The PCR condition for unmethylated alleles of BMP6 was 12 min at 95˚C, 40 cycles of 30 sec of 95˚C, 60 sec of 60˚C and 60 sec of 72˚C, followed 7 min elongation. PCR products were separated by electrophoresis and visualized on an ethidium bromidestained 2.5% agarose gel. DNA from non-malignant lung tissue was treated with SssI methyltransferase (New England BioLabs, Beverly, MA) and then subjected to bisulfite treatment was used as a positive control for methylated alleles.
5-Aza-2'-deoxycytidine treatment.
Cell lines were treated with 5-aza-2'-deoxycytidine (5-Aza-CdR) (Sigma-Aldrich, St. Louis, MO) at a concentration of 1-2 μg/ml for 6 days with medium changes on days 1, 3 and 5. Treated or untreated cell from individual triplicate flasks were harvested to detect expression level using RT-PCR as described earlier. Two MPM cell lines (NCI-H290, NCI-H28) with weak and negative BMP3b expression were used for this assay. RT-PCR for each gene was carried out using two cycles, 17 and 35. The expression of BMP3b was completely suppressed in NCI-H2372 and NCI-H28. But in two weak expressing cell lines; NCI-H2052 and H290, BMP3b amplicon was not detected using 17 cycles but observed using 35 cycles. BMP6 amplicon in NCI-H2372 and NCI-H290 was not detected using 17-cycle amplification. GAPDH was used as internal control.
Data analysis.
A comparison of the proportion of gene methylation was done using Fisher's exact test. A P-value <0.05 was defined as being statistically significant. All data were analyzed with the use of Survival Tools for StatView (Adept Scientific Inc., Acton, MA).
Results
The expression of BMP3b and BMP6 was examined in 7 MPM cell lines by RT-PCR (Fig. 1) . RT-PCR is not a quantitative assay for expression, but 2 different amplification cycles, 17 and 35 cycles; of PCR distinguished complete suppression or partial suppression of these genes. The expression of BMP3b was completely suppressed in 2 cell lines; NCI-H2372 and NCI-H28; and partially suppressed in 2 cell line; NCI-H2052 and NCI-H290, while expression of BMP6 was partially suppressed only in 2 cell lines. Methylation status of BMP3b in cell lines was determined by MSP assay (Fig. 2) . DNAs which were amplified with primers for methylated alleles but not with primers with unmethylated alleles were determined to be heavily methylated. DNAs which were amplified with both methylated and unmethylated primer sets were considered to be partially methylated. In 7 MPM cell lines, 2 cell lines (NCI-H290 and NCI-H28) were strongly methylated and 4 cell lines (NCI-H2452, HP1, NCI-H2058 and NCI-H2052) were partially methylated in the BMP3b gene. NCI-H28 in which BMP3b expression was not present was strongly methylated, but NCI-H2372 with negative expression was not methylated. Two cell lines with weak expression of BMP3b were heavily (H290) and partially methylated (H2052). By contrast, expression of BMP3b was not suppressed in 3 cell lines with partial methylation (NCI-H2452, HP1 and NCI-H2058). In the BMP6 gene, only two cell lines (NCI-H2373 and NCI-H290) were partially methylated and no cell lines were heavily methylated. The expression of these two cell lines was partially suppressed.
Next, methylation status in 57 surgically resected MPM cases was tested by MSP assay (Fig. 2) . Because nonmalignant cells were contained in surgically resected samples, all primary samples were amplified with primers for unmethylated alleles. Aberrant methylation of BMP3b were found in 9 (53%) out of 17 cases from Japan and 3 (8%) of 40 cases from USA and that of BMP6 were in 4 (24%) cases from Japan and 12 (30%) cases from USA (Table I) . While the frequency of BMP6 methylation was similar in MPMs in Japan and USA, but BMP3b methylation was significantly frequent in Japanese patients (P=0.0004).
To confirm the responsibility of DNA methylation for BMP3b silencing, we treated two methylated cell lines (NCI-H290, NCI-H28) with 5-Aza-CdR. BMP3b expression was significantly up-regulated by 5-Aza-CdR treatment in methylated cell lines (Fig. 3) . ---------------------------------------------------------------------------------------------------- formation. They are members of the transforming growth factor-ß (TGF-ß) superfamily and critical mediators of early embryonic patterning. BMPs have shown to inhibit cellular proliferation and involved in organogenesis, particularly of the lung, heart and kidney. Recent work has shown that BMP3b and BMP6 are epigenetically inactivated in several malignancies. BMP3b has been demonstrated to be methylated in NSCLCs, and colorectal cancer, and BMP6 gene in NSCLCs, prostate cancer, malignant lymphomas and breast cancer (9) (10) (11) (12) (13) .
We have screened for aberrant methylation of BMP genes in MPMs. In spite of the limitation of the number of cell lines and primary samples, we showed the suppression of BMP3b and BMP6 expression in MPM cell lines and DNA methylation was one of the mechanisms of gene suppression. Aberrant methylation of BMP3b and BMP6 was also detected in primary MPMs. The frequency of methylation of BMP6 was quite similar in cell lines, primary tumors in USA and those in Japan, but methylation of BMP3b gene was significantly more frequent in MPMs of Japan than those of USA. These results indicate that the methylation of BMP3b may be influenced by ethnic or pathogenic differences. Of note, we have reported that the methylation of insulin-like growth factor binding protein-3 was significantly more frequent in Japanese MPMs than in those of USA (15) .
As shown in Fig. 1 , methylated and unmethylated bands were observed in 4 cell lines, indicating partial methylation. In addition, even partial methylated cell lines, expression status was not identical. These finding suggest heterogeneity of methylation among individual cells even in the same cell lines. The importance of partial methylation of BMP3b is not clear and further study is necessary. Of note, the seven cell lines examined were established in USA, but the frequency of methylation in primary tumors in USA is not frequent. Thus, partial methylation in cell lines might be artificial phenomenon in the process of establishing cell lines. Furthermore, there must be other mechanisms for gene suppression of BMP3b because it was completely suppressed in NCI-H2372, in which DNA methylation was absent.
Recent work of others and our study strongly support that BMP3b and BMP6 have a role as tumor suppressor genes in several malignancies. Other members of BMPs are shown to be involved in malignancies but their roles in carcinogenesis are still controversial. Methylation and loss of expression of BMP2 was observed in gastric carcinomas, but it was also shown to promote tumor growth in A549, NSCLC cell lines (16) . The roles of BMP proteins in carcinogenesis may be different according to the organ and further studies are necessary.
In conclusion, we showed that DNA methylation cause the suppression of BMP3b and BMP6 expression in MPMs. In addition, there was an ethnic difference of frequency of the methylation in BMP3b, suggesting the etiology of MPM may be different between Japanese and USA.
